Investigational Site Number 8260002

Cambridge CB2 OQQ

0 studies enrolling now · 1 studies all time

What they study most

Glycogen Storage Disease Type II;Pompe's Disease

Studies at this site

• Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease — Completed